Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-09-03, Stock:JNJ, The news for the past five days is as follows:
2021-08-27: NEWS1: SCAN Health Plan CEO on reducing Covid-19 vaccine disparities among minorities.NEWS2: US Judge Allows Johnson & Johnson To Split Talc Powder Liabilities Into New Company.NEWS3: NIH starts study of COVID-19 booster shot in people with autoimmune diseases.NEWS4: Pfizer (PFE) Inks Deal With Eurofarma to Make COVID-19 Vaccine.NEWS5: 3 Top-Quality Dividend Stocks for a Secure Retirement.NEWS6: Pharma Stock Roundup: PFE's COVID Jab Full Approval by FDA, JNJ's Booster Data.NEWS7: The Challenges Vaccine Stocks Face As They Try To Fight Delta Variant.NEWS8: 7 Safe Stocks To Buy for an Increasingly Unstable World.
2021-08-30: NEWS1: Johnson & Johnson (JNJ) Gains But Lags Market: What You Should Know.NEWS2: Doctor on booster shots: 'What we may be talking about is a vaccine that requires 3 shots'.NEWS3: Early polls & surveys show there’s about a 25% likelihood that parents are going to vaccinate their kids: Doctor.NEWS4: Why Johnson & Johnson (JNJ) is a Great Dividend Stock Right Now.NEWS5: Scientists debate the need for booster shots.NEWS6: UK's NICE Rejects Johnson & Johnson's Darzalex Regime For Newly Diagnosed Myeloma.
2021-08-31: NEWS1: Doctor: Pediatric hospital units are 'getting stretched' due to Delta variant.NEWS2: 15 Best Pharmaceutical Stocks to Invest In.NEWS3: 5 Best Pharmaceutical Stocks to Invest In.NEWS4: Outcry Continues to Grow for Johnson & Johnson to Resolve Talc-Cancer Claims After Latest Jury Verdict.NEWS5: J&J’s potential HIV vaccine falls short in sub-Saharan Africa trial.NEWS6: UPDATE 1-Nigeria prioritising four COVID-19 vaccines, not including Sinopharm.NEWS7: Unvaccinated Americans are ‘irresponsibly filling up our ERs and ICUs’: doctor.NEWS8: UPDATE 2-J&J's HIV vaccine fails trial in latest blow to the field.NEWS9: Johnson & Johnson's HIV vaccine fails mid-stage study in Africa.NEWS10: Johnson & Johnson and Global Partners Announce Results from Phase 2b Imbokodo HIV Vaccine Clinical Trial in Young Women in Sub-Saharan Africa.NEWS11: Johnson & Johnson HIV Vaccine Candidate Fails Mid-Stage Trial.
2021-09-01: NEWS1: ‘All the teachers should be mandated now to get the vaccine’: Doctor.NEWS2: FDA Approves First And Only Twice-Yearly Schizophrenia Drug.NEWS3: J&J's (JNJ) HIV Vaccine Study in Young African Women Fails.NEWS4: 2 FDA officials reportedly resign over Biden administration booster-shot plan.NEWS5: 10 Dividend Stocks with Over 9% Yield.NEWS6: Elizabeth Holmes trial: The 5 biggest takeaways from 'Valley of Hype'.
2021-09-02: NEWS1: Former Biden COVID-19 adviser calls for vaccine mandate for teens.NEWS2: Battle Against Johnson & Johnson "Texas Two-Step" Ploy Moves to New Jersey.NEWS3: Europe To Return Johnson & Johnson COVID-19 vaccines Shipped From South Africa: WSJ.NEWS4: Todos Medical launches test that measures COVID-19 antibody levels.NEWS5: Data is starting to support the need & timeline for a Covid-19 booster vaccine: Virologist.NEWS6: 7 Healthcare Stocks to Buy Before $3.5 Trillion Floods In.NEWS7: Why Elizabeth Holmes, Theranos saga has cast a 'long shadow' on female-led startups.NEWS8: Moderna (MRNA) Gives First COVID Jab Booster Data to the FDA.NEWS9: J&J (JNJ) Gets FDA Nod for Twice-Yearly Schizophrenia Drug.NEWS10: 'The vaccine is our most powerful tool,' nurse stresses amid Delta variant surge.NEWS11: UPDATE 2-S.Africa's Aspen seeks licence for J&J COVID shot as EU shipments halted.NEWS12: Love Dividends? 2 Stocks You Might Want to Buy.NEWS13: Aspen eyes Serum Institute model as it seeks licence to make J&J vaccine.NEWS14: UPDATE 1-J&J vaccine shipments from S.Africa to Europe halted, AU says.NEWS15: Aspen in talks with J&J to produce and market COVID-19 vaccine.

Answer: Rise